Kyung Young Chung

Kyung Young Chung

Auto-generated profile, based on publicly available information

Kyung Young Chung

Department of Thoracic and Cardiovascular Surgery, Yonsei University College of Medicine, Seoul, Korea

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 December 2014 in Journal of Nuclear Medicine
Verified
Journal Article
Closed access
PDF file
SPSeong Yong Park
Seong Yong Park
ACArthur Cho
Arthur Cho
WYWoo Sik Yu
Woo Sik Yu
CLChang Young Lee
Chang Young Lee
JLJin Gu Lee
Jin Gu Lee
KCKyung Young Chung
Kyung Young Chung
Despite the favorable prognosis of stage IA non–small cell lung cancer (NSCLC), the disease recurs after complete surgical resection in 20%–30% of patients. This study determined the prognostic value of various metabolic parameters of 18F-FDG PET/CT in surgically resected stage IA NSCLC. Methods: We retrospectively reviewed 248 patients with stage IA NSCLC who underwent lobectomy and complete lymph node dissection after PET/CT. A region of interest was drawn on the primary lesion, and metabolic indices such as metabolic tumor volume, maximum standardized uptake value (SUVmax), and total lesion glycolysis (TLG) were measured using an SUV cutoff of 2.5. Results: The patients included 134 men and 114 women, and the mean age was 63.03 ± 10.01 y; 129 were stage T1a (≤2 cm) and 119 were T1b (>2 cm). The median follow-up period was 36.6 mo. Recurrence took place in 15 patients. The mean (±SD) SUVmax, metabolic tumor volume, and TLG were 4.55 ± 3.75, 5.92 ± 5.57, and 14.42 ± 17.35, respectively. The cutoffs of SUVmax and TLG were 3.7 and 13.76, respectively. The 5-y overall survival (OS) was 95.1% in low-SUVmax patients and 82.2% in high-SUVmax patients (P = 0.02). The 5-y OS was 93.7% in low-TLG patients and 78.3% in high-TLG patients (P = 0.01). On multivariate analysis, TLG was a risk factor for OS (hazard ratio, 3.159; P = 0.040), but SUVmax showed marginal significance (P = 0.064). The concordance index of the TLG model was 0.676 (95% CI, 0.541–0.812). Conclusion: TLG was a significant prognostic factor for OS in patients with stage IA NSCLC.

9 November 2015 in Respiratory Research
Verified
Journal Article
Open access
PDF file
JLJin Gu Lee
Jin Gu Lee
JSJu Hye Shin
Ju Hye Shin
HSHyo Sup Shim
Hyo Sup Shim
CLChang Young Lee
Chang Young Lee
DKDae Joon Kim
Dae Joon Kim
KCKyung Young Chung
Kyung Young Chung
The development of chemo-resistance in non-small lung cancer is a major obstacle in treating patients. Hypoxia is a commonly faced microenvironment in solid tumor and suggested to be related to both autophagy and chemo-resistance. In this study, we investigated the role of hypoxia-induced autophagy in acquiring chemo-resistance in both cancer cell (A549) and human cancer tissue Hypoxic exposure (1 % O2) of A549 cell stimulated autophagic induction in cancer cells, shown by increase of LC3BI to LC3BII conversion and decrease of p62/sequestosome1 in Western blot, increased GFP-LC puncta in confocal microscopy, and increased number of double-membrane autophagic vacuoles in electron micrographs. Hypoxic exposure also induced resistance of cancer cells to cisplatin, and LC3B siRNA restored the sensitivity of cancer cells to chemotherapy. Furthermore, Human lung cancer tissues that experienced chemotherapy showed increase of LC3BI to LC3BII conversion and decrease of p62/sequestosome1 compared with chemo-naïve cancer tissue in Western blot. Autophagy may play an important role in acquiring resistance to chemotherapy in lung cancer and hypoxia related pathway seems to be involved in autophagy induction.

1 September 2015 in The Annals of Thoracic Surgery
Verified
Journal Article
Closed access
CBChun Sung Byun
Chun Sung Byun
SLSungsoo Lee
Sungsoo Lee
DKDae Joon Kim
Dae Joon Kim
JLJin Gu Lee
Jin Gu Lee
CLChang Young Lee
Chang Young Lee
KCKyung Young Chung
Kyung Young Chung

11 June 2013 in Journal of Cardiothoracic Surgery
Verified
Journal Article
Open access
PDF file
SPSeong Yong Park
Seong Yong Park
JLJin Gu Lee
Jin Gu Lee
JKJieun Kim
Jieun Kim
GBGo Eun Byun
Go Eun Byun
MBMi Kyung Bae
Mi Kyung Bae
KCKyung Young Chung
Kyung Young Chung
Background: Although overall survival for non-small cell lung cancer (NSCLC) has increased, survival rate for pathologically staged T2aN0M0 stage IB NSCLC remains low. Adjuvant chemotherapy is not a standard treatment for stage IB NSCLC. Our purpose was to determine the efficacy of platinum-based adjuvant chemotherapy in stage IB NSCLC. Methods: We retrospectively reviewed the medical records of 119 stage IB patients who underwent lobectomy and mediastinal lymph node dissection. Among these, 60 patients underwent platinum-based adjuvant chemotherapy (adjuvant group) and 59 did not receive chemotherapy (observation group). Results: Participants had a mean age of 62.12 ± 11.51 years and 73 (61.3%) were male. The median follow-up period was 49.04 months. Mean age was higher in the observation group whereas patients in the adjuvant group had larger tumors, more dissected lymph nodes, and better performance status. The 5-year overall survival was 64.7% in the observation group and 88.2% in the adjuvant group (p = 0.010). The 5-year disease-free survival was 51.3% in the observation group and 74.0% in the adjuvant group (p = 0.011). In multivariate analysis, only platinum-based adjuvant chemotherapy was a risk factor for overall survival [hazard ratio (HR) = 0.428, p = 0.049] and disease-free survival (HR = 0.57, p = 0.043). In subset analysis, patients with a larger tumor (greater than 3.2 cm), moderate to poor differentiation, and good performance status (Eastern Cooperative Oncology Group, 0) benefitted from platinum-based adjuvant chemotherapy. Conclusions: Platinum-based adjuvant chemotherapy for surgically treated stage IB NSCLC might offer better survival than observation alone. A large-scale randomized clinical trial is needed to validate these findings.

1 November 2016 in Lung Cancer
Verified
Journal Article
Closed access
KNKyoung Shik Narm
Kyoung Shik Narm
CLChang Young Lee
Chang Young Lee
YDYoung Woo Do
Young Woo Do
HJHee Suk Jung
Hee Suk Jung
GBGo Eun Byun
Go Eun Byun
KTKorea Association for Research on the Thymus
Korea Association for Research on the Thymus

19 August 2010 in Surgical Endoscopy
Verified
Journal Article
Closed access
PDF file
CLChang Young Lee
Chang Young Lee
DKDae Joon Kim
Dae Joon Kim
JLJin Gu Lee
Jin Gu Lee
IPIn Kyu Park
In Kyu Park
MBMi Kyung Bae
Mi Kyung Bae
KCKyung Young Chung
Kyung Young Chung